Nevertheless, the statistical significance in OS and RFS between TNBC grade 3 tumors expressing high levels versus low levels of FATP1/SLC27A1, is a strong indication that FATP1 plays a role in BC progression and outcome, suggesting that its usefulness as an outcome marker and therapeutic target deserves to be explored. This evidence concerns the gene SLC27A1 and breast cancer.